[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100588841":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":18,"locations":24,"responsibleParty":35,"collaborators":10,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":45,"eligibilityCriteria":46,"healthyVolunteers":41,"sex":47,"minAge":48,"maxAge":10,"enrollmentInfo":49,"targetDuration":10,"studyType":52,"phases":10,"briefSummary":53,"conditions":54,"keywords":57,"overallStatus":60,"whyStopped":10,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":70},{"fullName":5,"class":6},"Peking University People's Hospital","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Geriatric Assessment",null,[12],"Procedure: Geriatric Assessment",[14],{"type":15,"name":9,"description":16,"armGroupLabels":17,"otherNames":10},"PROCEDURE","This is a study held in all patients undergoing allogenic hematopoietic stem cell transplantation. Pre-transplant assessment: (1)Patients-related assessment: (a) Age; (b) Functional status (BADL score; IADL score; KPS score; ECOG PS score); (c) Comorbidities (HCT-CI score); (d) Nutritional Status (Body weight; BMI; NRS-2002; MNA-SF; MUST); (e) Psychological Status (SF36-MCS; GDS; PHQ-9; GAD-7); (f) Cognitive Function (MMSE; BMOC); (g) Social Support Level (MOS-SSS; MSPSS); (h) Total Number of Medications Used. (2) Disease-Related Factors Assessment: Primary Disease Diagnosis; ELN Risk Stratification (assessed only for AML patients); Disease Status. (3) Donor-Related Factors Assessment: Donor Age; Donor Sex; Donor-Recipient Blood Type Compatibility; Donor Type; DSA. (4) Treatment-Related Factors Assessment: Conditioning Regimen; GVHD Prophylaxis Regimen; Graft Type.",[9],[19],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"Yuqian Sun","CONTACT","861088326666","sunyuqian83@hotmail.com",[25],{"facility":5,"status":10,"city":26,"state":10,"zip":10,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":10},"Beijing","China","CN",{"type":30,"coordinates":31},"Point",[32,33],116.39723,39.9075,{"lat":33,"lon":32},{"type":36,"investigatorFullName":37,"investigatorTitle":38,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Sun Yuqian","Associate Professor","100588841","geriatric-assessment-ga-for-elderly-patients-undergoing-allo-hsct-100588841",false,"NCT06946654","Geriatric Assessment (GA) for Elderly Patients Undergoing Allo-HSCT","Geriatric Assessment (GA) for Elderly Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: a Prospective Study.","GA","Inclusion Criteria:\n\n* (a)Age ≥55 years.\n* (b)Hematologic disorders with established indications for transplantation, including malignant and non-malignant hematologic diseases. (c)Willingness to provide informed consent.\n\nExclusion Criteria: (a)Pregnancy. (b) Uncontrolled active infection. (c) Lack of informed consent. (d)Deemed ineligible for transplantation after investigator assessment","ALL","55 Years",{"count":50,"type":51},176,"ESTIMATED","OBSERVATIONAL","This comprehensive, multidimensional evaluation assesses patient-related factors, disease-related factors, donor-related factors, and treatment-related factors. The study aims to identify potential risk factors influencing transplant outcomes in elderly patients and enhance the outcomes of allo-HSCT.",[55,9,56],"Elderly","ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION",[58,9,59],"elderly","allo-HSCT","NOT_YET_RECRUITING","2025-05-09",{"date":63,"type":64},"2025-05-11","ACTUAL",{"date":66,"type":51},"2025-05-20",{"date":68,"type":51},"2027-03-31",{"name":5,"class":6},1]